THE UNMASKING OF AMYLOID
Main Article Content
Keywords
Abstract
Introduction: Amyloidosis was first described by Virchow. Early detection of amyloidosis is essential as there are effective treatments for the primary causes. The progression and severity of the disease can be halted with newer treatments. The cause of amyloidosis often remains elusive. Amyloidosis is usually incidentally detected in biopsies.
Aim: We aim to evaluate the clinical features and histomorphological findings and document the occurrence of rare presentations of amyloidosis.
Materials and methods: The cases documented as organ amyloidosis were collected from the casefiles and records. The amyloidosis associated with skin and neoplastic lesions are excluded. The histopathological slides and congored stained slides were reviewed with analysis of the microscopic features. Polarizing microscopy was performed to confirm the diagnosis.
Results: These included a total of 14 cases. Three cases of larynx, two each of peripheral nerves and abdominal fat, along with one each of heart, gastric, duodenum, colon, liver, pancreas and spleen are included in the study. The age range was 35 years to 84 years. The median age was 62 years. Male predominance (71%) was noted. Most common organ involved in the present series was larynx.
Conclusion: This is a review of the rare cases of amyloidosis which had unusual presentation and histopathology finally revealed the diagnosis. High suspicion of amyloidosis can help in early diagnosis. Careful histomorphological analysis recognizes the patterns in which this disease entity can present, so that early lesions can also be subjected to special staining with congo red and polarized microscopy for early treatment and to minimize complications and morbidity.
References
2. Walter JB, Talbot IC: Amyloidosis. In: Walter JB, editor. Walter & Israel General Pathology, 7th Ed. Noida: Churchill Livingstone; 2009. p.791.
3. Hawkins P: The Amyloidoses. In: Strayer DS, Rubin E, editors. Rubin’s Pathology Clinicopathologic Foundations of Medicine, 7ed. Philadelphia: Wolter Kluwer; 2012. P.563.
4. Bhardwaj JR, Deb P: Immunologic Disorders. In: Bharadwaj JR, editor. Boyd’s Textbook of Pathology, 10th Ed. New Delhi: Wolters Kluwer Health; 2013. p.196.
5. Mitrani M, Biller HF. Laryngeal amyloidosis. Laryngoscope. 1985 Nov;95:1346-7.
6. Ginat DT, Schutle J, Portugal L, Cipriani NA. Laryngotracheal involvement in systemic light chain amyloidosis. Head and Neck Pathol 2018;12:127-30.
7. Yiotakis I, Georgolios A, Charalabopoulos A, Hatzipantelis P, Golias C, Charalabopoulos K, Manolopoulos L. Primary localized laryngeal amyloidosis presenting with hoarseness and dysphagia: a case report. J Med Case Rep. 2009;3:9049.
8. Daudia A, Motamed M, Lo S. Primary amyloidosis of the larynx. Postgrad Med J. 2000;76:364-5.
9. Aubrey-Bassler AK, Sowers N: 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emergency medicine 2012;12: 11.
10. Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D. Systematic review of atraumatic splenic rupture. Br J Surg. 2009;96:1114-21.
11. Oran B, Wright DG, Seldin DC, McAneny D, Skinner M, et al. Spontaneous rupture of the spleen in AL amyloidosis. Am J Hemat. 2003;74:131-5.
12. Bhattacharya B. Non neoplastic disorders of the stomach. In: John R. Goldblum, editor. Gastrointestinal and Liver pathology. , 2nd edition. Philadelphia, 2012. P 126-30.
13. Ichimata S, Kobayashi M, Shimojo H, Katoh N, Yazaki M, Kanno H. Usefulness of gastroduodenal biopsy in the differential diagnosis of systemic AH amyloidosis from systemic AL amyloidosis. Histopathology. 2018;73:230-239.
14. Fengoglio-Preiser C M, Noffsinger AE, Stemmermann GN, Lantz PE, Isaacson PG. The Nonneoplastic Colon. In: Cecilia M, editor. Gastrointestinal Pathology. An Atlas and Text, 3rd Ed. Philadelphia: Wolter Kluwers; 2008; P867.
15. Said S M, Karen L. Grogg K L, Thomas C. Smyrk T C. Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution. Hum Pathol 2015;46:491-8.
16. MatsudaY. Age-related pathological changes in the pancreas. Frontiers in Bioscience. 2018;10:137-42.
17. Picken MM. Amyloidosis-Where are we now and where are we heading?. Arch Pathol Lab Med. 2010;134:545-51.
18. Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt. Sinai J Med. 2012;79:733-48.
19. Agaram NP. Liver Pathology in Systemic Diseases. In: Saxena R, editor. Practical Hepatic pathology- A diagnostic approach. Philadelphia: Elsevier; 2011. p.567-8.
20. Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Seminars in histopathology. Access: http://dx.doi.org/10.1016/S0140-6736(15)01274-X\ (Accessed on 14th August 2018).
21. Magesh B, Kadeli D, Bohra S, Krishnaprasath V, Keshava R. Cardiac amyloidosis, an infiltrative heart disease presenting as arrhythmia- A case report. JCDR. 2017;11:14-5.